ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO595

Functional Studies of Polycystin-1 Using a Novel Pkd1-HaloTag Mouse

Session Information

Category: Genetic Diseases of the Kidneys

  • 1201 Genetic Diseases of the Kidneys: Cystic

Authors

  • Cordido, Adrian, Yale University, New Haven, Connecticut, United States
  • Dong, Ke, Yale University, New Haven, Connecticut, United States
  • Cai, Yiqiang, Yale University, New Haven, Connecticut, United States
  • Tian, Xin, Yale University, New Haven, Connecticut, United States
  • Wei, Zemeng, Yale University, New Haven, Connecticut, United States
  • Rehman, Michael, Yale University, New Haven, Connecticut, United States
  • Somlo, Stefan, Yale University, New Haven, Connecticut, United States
Background

Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disease caused primarily by mutations in genes encoding Polycystin-1 (PC1) and Polycystin-2 (PC2). The physiological function of polycystins and the process through which their dysfunction leads to cystogenesis remains unclear. The localized expression of PCs, particularly PC1, in kidney and other tissues has been challenging to detect. HaloTag is a versatile protein labeling system which allows antibody independent covalent ligand-based labeling of the targeted protein and can improve the sensitivity and intensity of the protein localization signals. We applied this system to PC1 in vivo.

Methods

Based in our preliminary data in transfected cells showing that PC1-HaloTag expression can be detected by HaloTag ligand labeling in western blotting and live cell immunofluorescence, we produced a Pkd1-knockin mouse with a C-terminal fusion of 3XHA-HaloTag with PC1 (PC1Halo). We characterized the viability and kidney phenotype of the mice and the maturation and expression of PC1Halo by western blotting and confocal immunofluorescence microscopy.

Results

Pkd1Halo/Halo mice are born in normal Mendelian ratios and have normal renal and liver phenotypes at 6 months age indicating that PC1Halo is fully functional in vivo. Adult induced Pkd1fl/Halo; Pax8rtTA; TetO-Cre mice are also normal. We detected normal maturation of PC1Halo by western blot of multiple tissue lysates and primary kidney cell cultures from Pkd1Halo/Halo mice. We detected endogenous PC1Halo in cilia of primary kidney cell culture from Pkd1Halo/Halo mice by confocal imaging following HaloTag ligand labeling in live cells as well as fixed cells.

Conclusion

PC1 C-terminal fusion with HaloTag produces a fully functional PC1Halo in vivo. Endogenous PC1Halo can be detected in tissue lysates and can be imaged in primary kidney cell cultures. PC1Halo will be a useful tool for exploring native PC1 in vitro and in vivo.